can glp 1 cause leg pain The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 Joint, Muscle, & Nerves

Evidence Linking GLP-1 Agonists to Pancreatitis Risk The evidence regarding GLP-1 agonists and pancreatitis risk remains complex and somewhat contradictory , with different studies yielding varying conclusions

Additionally, FDA does not consider convenience in administering a particular compounded drug product (e.g., a ready-to-use form) or the cost of the compounded drug product as compared with an FDA-approved drug product when assessing clinical need. The notice also states that the FDA carefully reviewed the nominations it received and it did not identify sufficient evidence to include semaglutide, tirzepatide, and liraglutide on the 503B Bulks List

Remember that while it's rare, menstrual changes can signal more serious conditions

A research study looking at how 50 mg semaglutide daily affects food intake and emptying of the stomach in people with obesity